CNS Pharmaceuticals (CNSP) SEC Filings & 10K Form $6.70 -0.29 (-4.15%) Closing price 04:00 PM EasternExtended Trading$6.88 +0.18 (+2.69%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent CNS Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView07/15/20254:19 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/14/20257:59 AMCNS Pharmaceuticals (Filer)Form 424B405/13/202511:15 PMCNS Pharmaceuticals (Filer)Form EFFECT05/12/20255:03 AMCNS Pharmaceuticals (Filer)Form S-1/A04/09/20252:32 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/31/20254:11 PMCNS Pharmaceuticals (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/31/20254:12 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/20/20254:17 PMCNS Pharmaceuticals (Filer)Form 424B503/20/20254:15 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/21/20254:00 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/11/202411:24 AMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/15/20243:19 PMCNS Pharmaceuticals (Filer)Form DEFR14A11/01/20248:00 AMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/28/20243:15 PMCNS Pharmaceuticals (Filer)Form DEF 14A10/24/20244:27 PMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/24/202410:23 AMCNS Pharmaceuticals (Filer)Form 424B510/23/20247:02 AMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/15/20244:24 PMCNS Pharmaceuticals (Filer)Form PRE 14A09/12/20247:58 AMCNS Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20244:22 PMCNS Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Citius Pharmaceuticals 10K Form AlloVir 10K Form ProPhase Labs 10K Form NextCure 10K Form Lixte Biotechnology 10K Form Carisma Therapeutics 10K Form Sensei Biotherapeutics 10K Form TherapeuticsMD 10K Form Trinity Biotech 10K Form Leap Therapeutics 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CNSP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shi...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNSP Stock Alerts